168828-71-5Relevant articles and documents
Spectroscopic identification of intermediates and final products of the chiral pool synthesis of sutezolid
Bocian, Wojciech,Cielecka-Piontek, Judyta,Lewandowska, Kornelia,Michalska, Katarzyna,Mizera, Miko?aj,Pa?ys, Barbara
, (2020/05/18)
Sutezolid is a new oxazolidinone derivative currently in clinical trials to determine its safety and efficacy towards highly drug-resistant tuberculosis. The aim of the study was the spectroscopic identification of selected key intermediate products of th
Syntheses and antibacterial activity studies of new oxazolidinones from nitroso Diels-Alder chemistry
Yan, Shanshan,Miller, Marvin J.,Wencewicz, Timothy A.,Moellmann, Ute
supporting information; experimental part, p. 1302 - 1305 (2010/06/15)
A series of novel oxazolidinone antibiotics having [2.2.1] and [2.2.2] bicyclic oxazine moieties at the C-5 side chain of the A-ring was synthesized by nitroso Diels-Alder reactions, from three linezolid analogs containing morpholine, piperazine and thiomorpholine, respectively, as the C-ring components. Subsequent N-O bond cleavage generated oxazolidinones with 4-amino cyclo-2-en-1-ol substituents. The in vitro antibacterial activities of these oxazolidinone analogs were evaluated.
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
Barbachyn, Michael R.,Hutchinson, Douglas K.,Brickner, Steven J.,Cynamon, Michael H.,Kilburn, James O.,et al.
, p. 680 - 685 (2007/10/03)
During the course of our investigations in the oxazolidinone antibacterial agent area, we have identified a subclass with especially potent in vitro activity against mycobacteria. The salient structural feature of these oxazolidinone analogues, 6 (U-10048